Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

171.94
Delayed Data
As of May 22
 +3.37 / +2.00%
Today’s Change
150.06
Today|||52-Week Range
203.30
-7.07%
Year-to-Date

Today’s Trading

Previous close168.57
Today’s open167.69
Day’s range167.31 - 172.65
Volume2,570,610
Average volume (3 months)1,731,684
Market cap$34.3B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)+0.23%
Earnings growth (next 5 years)+21.56%
Revenue growth (last year)+46.49%
P/E ratio58.9
Price/Sales16.55
Price/Book10.37

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.28-0.40%
VRTXVertex Pharmaceutica...+0.03+0.02%
PRGOPerrigo Company PLC+0.21+0.11%
ZTSZoetis Inc-0.17-0.36%
Data as of 4:02pm ET, 05/22/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$1.38
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers